Company Filing History:
Years Active: 1998-2010
Title: Philippe Becourt: Innovator in Pharmaceutical Compositions
Introduction
Philippe Becourt is a notable inventor based in Massy, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on innovative pharmaceutical compositions and formulations.
Latest Patents
One of his latest patents is titled "Pharmaceutical compositions comprising trimegestone." This invention concerns a pharmaceutical composition that includes trimegestone, optionally associated with an estrogen. It is characterized by a buffer solution with a pH ranging between 2 and 5.5 when introduced into the composition. The invention also encompasses methods for creating such a composition and the primary packaging that contains it.
Another significant patent is "Pharmaceutical formulation having a masked taste and method for the production thereof." This invention relates to a pharmaceutical formulation in powder form, administered orally in an aqueous suspension. It features a masked taste and includes at least one cellulose polymer, a methacrylic polymer, and an active ingredient distributed homogeneously in a molecular state within an atomized matrix. Additionally, it contains an alkaline agent and an adsorbing agent, along with methods for its production and taste masking.
Career Highlights
Philippe Becourt has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma S.A. and Roussel Uclaf. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Throughout his career, Philippe has collaborated with notable professionals in the field, including Christian Desesquelle and Jean-Luc Dubois. These collaborations have likely enriched his work and led to further advancements in pharmaceutical inventions.
Conclusion
Philippe Becourt is a distinguished inventor whose work in pharmaceutical compositions has led to several important patents. His innovative approaches continue to impact the pharmaceutical industry positively.